Navigation Links
Fibroid Symptoms in Women can Be Relieved by Focused Ultrasound

A noninvasive ultrasound procedure effectively shrinks uterine fibroids and significantly relieves fibroid-related symptoms in women, according to the results of a multicenter clinical trial reported in the June issue of the journal Radiology. Magnetic resonance-guided, focused ultrasound surgery (MRgFUS) allows radiologists to precisely target fibroids without harming healthy surrounding tissue.

"This treatment immediately stops blood flow in the treated fibroid tissue, which results in a significant, sustained decrease in symptoms for up to 12 months," said the studys lead author, Fiona M. Fennessy, M.D., Ph.D., assistant professor of radiology at Harvard Medical School and staff radiologist at Brigham and Womens Hospital in Boston.

Uterine fibroids are benign growths of the muscle inside the uterus. According to the National Institutes of Health, at least 25 percent of women in the United States age 25 to 50 suffer from symptomatic uterine fibroids. Fibroid symptoms can include excessive menstrual bleeding, enlarged uterine size, frequent urination, pelvic pressure or pain and infertility.

According to the National Womens Health Information Center, fibroids are the primary reason for surgical removal of the uterus, accounting for approximately one-third of hysterectomies performed annually in the U.S. MRgFUS represents a noninvasive, outpatient alternative to hysterectomy.

"This treatment is ideal for older women who have completed their families and have a single or limited number of fibroids," said co-author Clare M. Tempany, M.D., professor of radiology at Harvard Medical School and director of Clinical Focused Ultrasound at Brigham and Womens Hospital.

The researchers studied 160 women with symptomatic fibroids. The women received pre-treatment MR imaging to identify and define the target fibroids. Radiologists then used MRgFUS to locate and treat the targeted fibroids while monitoring tem perature changes in tissue.

Ninety-six patients were treated under the original study protocol (A), and 64 patients were treated under an optimized protocol (B). Protocol A allowed a maximum treatment time of 120 minutes and a maximum fibroid treatment volume of 100ccs (roughly six centimeters (cm) in diameter), or up to 33 percent of total fibroid volume. Protocol B allowed a maximum treatment time of 180 minutes and maximum fibroid treatment volume of 150ccs (about seven cm in diameter), or up to 33 percent of total volume in subserosal fibroids (those on the outer wall of the uterus) and 50 percent of volume in non-subserosal fibroids.

"Through this study, weve learned that MRgFUS can be optimized with newer protocols to have even better results than previously thought possible," Dr. Tempany said.

The findings showed significant symptom relief at three months and sustained relief at one year. Women treated with the optimized protocol reported greater symptom relief and quality of life improvement than those treated with the original protocol. No serious adverse effects were reported.

"We have shown that treating fibroids with an optimized, less restrictive protocol allows for treatment of a greater fibroid volume, which results in even greater symptomatic relief at clinical follow-up," Dr. Fennessy said.


'"/>




Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Uterine Fibroid Embolization Gaining Popularity
3. Embolization Effective For Uterine Fibroid
4. Outpatient Treatment Possible For Patients with Uterine Fibroid Tumors
5. Does Treatment of Fibroids Guarantee Fertility ?
6. Mifepristone Reliable For Treating Uterine Fibroids
7. A hormone may decrease Menopause Symptoms
8. Heart Attack Symptoms in Women
9. Heart Attack Symptoms Different in Women
10. Symptoms Found To Be A Good Predictor Of Cancer Survival
11. Sudden Stress Found To Mimic Heart Attack Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... March 23, 2017 , ... On 2 ... Foundation the US Special Operations Command’s Patriot Award. The award was presented by ... Task Force Dagger Foundation for its significant and enduring support to the command. ...
(Date:3/23/2017)... ... , ... “Beyond and Back”: a true-life testimony of tragedy and the miraculous ... Bonetta Rose, a wife, mother and grandmother committed to sharing her many spiritual adventures ... Rose‘s new book presents actual events in the life of her family, which validate ...
(Date:3/23/2017)... ... 2017 , ... “The Trainer”: an electrifying and suspenseful gunslinger novel with ... with an active imagination and an enthusiasm for action and adventure stories. ... Bill Hart, who sat looking at the thirty-three notches that lined the edges of ...
(Date:3/22/2017)... , ... March 23, 2017 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... Asia Convention, currently taking place at the Suntec Singapore International Exhibition & Convention ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... consuming and frustrating and this tool bypasses that. Healthcare facilities across the ... an opportunity to offer their clients and hospitals, across the country, an efficient ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 BioLineRx Ltd. ... immunology, announced today that it has acquired Agalimmune Ltd., a ... consideration consisted of a $6 million upfront payment, of which ... shares. Additional future payments may be made based on development ... ...
(Date:3/23/2017)... March 23, 2017 AbbVie, a global biopharmaceutical ... choreographer Julianne Hough is helping to raise ... the Know about ME in EndoMEtriosis . "   ... women to learn about and understand endometriosis, a disease ... and to address their symptoms with a healthcare professional. ...
(Date:3/23/2017)... , March 23, 2017 ... in Brussels , My UV ... bad sun habits into life-saving ones, was awarded ... (AIM). Launched in 2016, the "Nudging for Good" ... easy and desirable for people to change behaviour ...
Breaking Medicine Technology: